The Development of Immunotherapeutic Strategies to Treat Haematological and Neoplastic Diseases on the Basis of Optimised Allogeneic Stem Cell Transplantation
Projektleitung an der Universität Würzburg:
Beteiligte Wissenschaftlerinnen und Wissenschaftler:
AlloStem is a cutting-edge blood and marrow transplantation research programme funded by the European Commission that will run for 42 months with the participation of leading immunologists and clinical scientists forming a consortium of 29-strong partners. AlloStem is an ambitious programme dedicated to improving cancer and leukaemia therapies and is being spearheaded by Professor Alejandro Madrigal, Scientific Director of The Anthony Nolan Trust in London, UK.
AlloStem secured the 8 million euro grant awarded by the European Commission, overcoming stark competition from Europe's most eminent research groups. This grant represents a watershed in European Union medical research funding and is so far the largest grant ever awarded to an immunotherapy programme in the region.
Laufzeit: von 04.2004 bis 09.2007
EU ( FP Allostem ) ,Genehmigungsdatum: 2004